Leading cannabis testing laboratories from the East and West Coast markets unite brands as BelCosta Labs
LONG BEACH, Calif., Nov. 30, 2022 (Globe Newswire) — BelCosta LaboratoriesToday, a leading third-party cannabis testing lab in California announced that the company is expanding its operations outside of California. BelCosta brings together the business and independent testing laboratories US Cannalytics (“USC”) and Pinnacle CT Labs (“PCT”). USC currently serves Florida, New Jersey, Pennsylvania and PCT services Maryland. All laboratories will be rebranded and operated as BelCosta Labs.
The merger brings together more than ten years of cannabis analytical testing experience from five different state markets to create a national laboratory group rooted in quality, transparency and innovation. The new group of labs is positioned to lead the evolution of the cannabis testing industry with best-in-class methodologies to provide operators, patients and consumers alike with detailed and accurate data to more effectively understand the cannabis experience.
““We are excited to expand our business out of state for the first time since starting BelCosta in 2017,” said BelCosta Labs CEO Myron Ronay. “As one of the oldest testing laboratories in a market as mature as California, we are eager to join forces with the US Cannalytics team to provide cannabis producers across the country with quality testing services and insights.”
Founded in 2018, USC and PCT is a multi-state group of independent testing laboratories serving the medical, recreational, and cannabis/CBD markets. As one of the largest cannabis testing organizations on the East Coast with more than seventy-five years of combined management experience across the medical, pharmaceutical, and other professional fields, USC and PCT have emerged as leaders in the East Coast markets.
The PCT is dedicated to ensuring a safe supply of medical cannabis patients in Maryland. The PCT scientific team includes professionals with a combined experience of more than 30 years in their respective fields.
“We are excited to join BelCosta Labs and work collaboratively with a great team to advance the cannabis testing industry,” said Carissa Miller, director of client services for USC and PCT. “USC and PCT pride ourselves on the expertise and extensive knowledge of our highly skilled team; joining BelCosta enhances our ability to exceed the minimum regulatory requirements and quality requirements of our current and future customer base.”
BelCosta Labs aims to use state-of-the-art analytical methods, dedicated technology, and a staff of nationally-renowned experts to provide high-quality compliance testing services to the cannabis industry.
About BelCosta Laboratories
BelCosta Labs is driving the evolution of cannabis lab testing through agricultural science, education, and technology. Bringing together analytical methods, dedicated technology, and years of experience in the cannabis industry to provide high-quality compliance testing lab services. BelCosta Labs is a member of the American Council on Independent Laboratories (ACIL) Cannabis Working Group, is ISO accredited by the American Association for Laboratory Accreditation (A2LA), and Certified by Americans for Safe Access (ASA). Our staff is comprised of nationally renowned agricultural science experts, who set the standards for rigorous testing methods and are committed to providing the best testing laboratory services and pushing the boundaries of agricultural science and research.
About US Cannalytics and Pinnacle CT Labs
US Cannalytics, LLC and Pinnacle CT Labs are a multi-state group of independent testing laboratories serving the medical marijuana/medical cannabis and hemp/CBD markets in MD, PA, FL and NJ. Currently, one of the largest privately owned, independent cannabis testing organizations on the East Coast, US Cannalytics and Pinnacle CT Labs provide world-class testing and services to our partners. With more than seventy-five years of combined management experience across the medical, pharmaceutical, and other professional fields, US Cannalytics and Pinnacle CT Labs leverage their extensive experience and knowledge to go beyond minimum regulatory, technical, and quality requirements.
Our core principles revolve around delivering consistently high quality results, using robust methods and processes, and nurturing genuine relationships within the cannabis industry and regulatory agencies. We are proud to provide the superior feedback needed to produce market leading products and ensure patient and consumer transparency and safety within the marketplace.
Subject to the approval of the regulatory authorities. The parties’ obligations under this Agreement are subject to all required regulatory approvals from each government regulatory agency.